Ignite Creation Date:
2025-12-25 @ 3:21 AM
Ignite Modification Date:
2026-03-04 @ 7:52 PM
Study NCT ID:
NCT02538705
Status:
COMPLETED
Last Update Posted:
2017-04-05
First Post:
2015-08-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy Study of Neovasculgen (Pl-VEGF165) Gene Therapy in Patients With Diabetic Foot
Sponsor:
Artgen Biotech
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
NeoFoot Pilot Study
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None